Vivos and SleepImage © Revolutionize Sleep Apnea Diagnostics with Affordable Home Sleep Testing Solutions [Yahoo! Finance]
Vivos Therapeutics, Inc. (VVOS)
Company Research
Source: Yahoo! Finance
In lab sleep testing can cost per night and access is limited and backlogged in many areas. New technology available through Vivos and SleepImage© is lowering costs and opening access for millions more to be tested and treated. LITTLETON, Colo. Dec. 4, 2024 /PRNewswire-PRWeb/ -- A staggering 70% of adults report experiencing insufficient sleep at least once a month, according to the US Centers for Disease Control and Prevention (CDC). (1) Despite this, 80% to 90% of sleep-related breathing disorders (SRBDs), such as obstructive sleep apnea (OSA), remain undiagnosed. (2) "The only way to identify SRBDs like OSA is through comprehensive screening and testing," explains Kirk Huntsman , Chairman and CEO of Vivos Therapeutics , a leading innovator in advanced medical technology for sleep and breathing health. "High costs and limited access to these critical diagnostic studies has left millions of Americans untreated, impacting their quality of life. At Vivos, we are dedicated to addressi
Show less
Read more
Impact Snapshot
Event Time:
VVOS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VVOS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VVOS alerts
High impacting Vivos Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
VVOS
News
- Vivos Therapeutics Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules [Yahoo! Finance]Yahoo! Finance
- Vivos Therapeutics Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesGlobeNewswire
- All You Need to Know About Vivos Therapeutics (VVOS) Rating Upgrade to Buy [Yahoo! Finance]Yahoo! Finance
- FDA-Cleared Therapy for Pediatric Sleep Apnea From Vivos Offers Parents and Providers New Hope [Yahoo! Finance]Yahoo! Finance
- FDA-Cleared Therapy for Pediatric Sleep Apnea From Vivos Offers Parents and Providers New HopePR Web
VVOS
Earnings
- 11/14/24 - Beat
VVOS
Sec Filings
- 12/23/24 - Form 8-K
- 12/20/24 - Form SCHEDULE
- 11/27/24 - Form 8-K
- VVOS's page on the SEC website